These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18591973)

  • 1. Nurturing European collaboration.
    Nat Rev Drug Discov; 2008 Jul; 7(7):548-9. PubMed ID: 18591973
    [No Abstract]   [Full Text] [Related]  

  • 2. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
    Kamel N; Compton C; Middelveld R; Higenbottam T; Dahlén SE
    Eur Respir J; 2008 May; 31(5):924-6. PubMed ID: 18448501
    [No Abstract]   [Full Text] [Related]  

  • 3. Leaders worry that U.S. is losing edge on cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration may be the cure for what ails drug development.
    Erickson AK
    Nat Med; 2004 Jun; 10(6):558. PubMed ID: 15170189
    [No Abstract]   [Full Text] [Related]  

  • 5. Arguments against precompetitive collaboration.
    Vargas G; Boutouyrie B; Ostrowitzki S; Santarelli L
    Clin Pharmacol Ther; 2010 May; 87(5):527-9. PubMed ID: 20407456
    [No Abstract]   [Full Text] [Related]  

  • 6. Open-minded to open innovation and precompetitive collaboration.
    Wagner JA
    Clin Pharmacol Ther; 2010 May; 87(5):511-5. PubMed ID: 20407451
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug discovery through industry-academic partnerships.
    Gray NS
    Nat Chem Biol; 2006 Dec; 2(12):649-53. PubMed ID: 17108976
    [No Abstract]   [Full Text] [Related]  

  • 8. European Pharma Oligonucleotide Consortium: A Move to Consolidate Oligonucleotide Knowledge and Share Experience Within the Community.
    Tivesten A; Akhtar N; Stolee J; Fillon Y; Orr R; Hill ML; Van den Bergh L; Huybrechts T; Muslehiddinoglu J; McCormac P; Amery J; Brecht A; Geiser A; Metzenthin T; Eichinger T
    Ther Innov Regul Sci; 2018 Nov; 52(6):687-688. PubMed ID: 30149734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project.
    Van Cauwenberge P; Watelet JB; Van Zele T; Bousquet J; Burney P; Zuberbier T;
    Allergy; 2005 Jul; 60(7):858-64. PubMed ID: 15932373
    [No Abstract]   [Full Text] [Related]  

  • 10. Sanofi takeover jeopardizes Aventis biotech deals.
    Mitchell P
    Nat Biotechnol; 2004 Jun; 22(6):639-40. PubMed ID: 15175667
    [No Abstract]   [Full Text] [Related]  

  • 11. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical Collaborations 2008--An SMi conference.
    Lakeram M
    IDrugs; 2008 May; 11(5):325-7. PubMed ID: 18465670
    [No Abstract]   [Full Text] [Related]  

  • 13. [The pharmacist in the European Economic Community].
    Pharm Weekbl; 1970 Mar; 105(12):349-53. PubMed ID: 5417311
    [No Abstract]   [Full Text] [Related]  

  • 14. The international serious adverse events consortium.
    Holden AL; Contreras JL; John S; Nelson MR
    Nat Rev Drug Discov; 2014 Nov; 13(11):795-6. PubMed ID: 25359365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International collaboration in health research.
    Lucas AO
    Bull World Health Organ; 2005 Jul; 83(7):482. PubMed ID: 16175818
    [No Abstract]   [Full Text] [Related]  

  • 16. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
    Bousquet J; Burney PG; Zuberbier T; Cauwenberge PV; Akdis CA; Bindslev-Jensen C; Bonini S; Fokkens WJ; Kauffmann F; Kowalski ML; Lodrup-Carlsen K; Mullol J; Nizankowska-Mogilnicka E; Papadopoulos N; Toskala E; Wickman M; Anto J; Auvergne N; Bachert C; Bousquet PJ; Brunekreef B; Canonica GW; Carlsen KH; Gjomarkaj M; Haahtela T; Howarth P; Lenzen G; Lotvall J; Radon K; Ring J; Salapatas M; Schünemann HJ; Szczecklik A; Todo-Bom A; Valovirta E; von Mutius E; Zock JP
    Allergy; 2009 Jul; 64(7):969-77. PubMed ID: 19392994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the drug-diagnostic divide.
    Opar A
    Nat Rev Drug Discov; 2011 May; 10(5):323-4. PubMed ID: 21532548
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 19. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 20. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
    D'Este P; Tribó JA; García-Romero A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.